- The 8th International Congress on Lipid & Atherosclerosis (ICoLA)
-
The 58th Fall Conference of the Korean Society of Lipid & Atherosclerosis
September 5 (Thu) ~ 7 (Sat), 2019
Conrad Seoul Hotel, Korea
Breakfast Symposia
- Page Path
-
- Program
- Breakfast Symposia
*(K) Korean Session
- BREAKFAST SYMPOSIUM 1
-
Sep. 6 (Fri.)
08:00~09:00 - Room 1
more
Chairperson
Deuk-Young Nah (Dongguk University, Korea)
| 08:00-08:05 | Opening Remark | |
| 08:05-08:25 | Moderate Intensity Statin Plus Ezetimibe vs. High Intensity Statin in Hypercholesterolemia Patients with CHD Risk Kwan Yong Lee (The Catholic University of Korea) | Abstract |
| 08:25-08:45 | A New Treatment Option in SGLT2 Inhibitor - Ertugliflozin Seung-Hwan Lee (The Catholic University of Korea) | Abstract |
| 08:45-08:55 | Discussion |
- BREAKFAST SYMPOSIUM 2
-
Sep. 6 (Fri.)
08:00~09:00 - Room 2
more
Chairperson
Jeong Euy Park (Park Jeong Euy Internal Medicine Clinic, Korea)
| 08:00-08:20 | A New and Powerful Solution for Dyslipidemia in Hypertension Kyung Woo Park (Seoul National University, Korea) | |
| 08:20-08:40 | Beyond LDL-Cholesterol Lowering Effect of CREZET Kwang-il Kim (Seoul National University, Korea) | Abstract |
- BREAKFAST SYMPOSIUM 3
-
Sep. 6 (Fri.)
08:00~09:00 - Room 3
more
Chairperson
Doo-Man Kim (Hallym University, Korea)
| 08:00-08:20 | LIPILOU-LAMP study : Atorvastatin Safety Study for Korean DyslipideMia Patients Hyung Joon Joo (Korea University, Korea) | |
| 08:20-08:40 | LIPILOU-NSC Study : Neurotrophic Effect of Atorvastatin in NSCs Agency Ischemic Injury Seong-Ho Koh (Hanyang University, Korea) | Abstract |
- BREAKFAST SYMPOSIUM 4
-
Sep. 7 (Sat.)
08:00~09:00 - Room 1
more
Chairperson
Sungwoo Park (Sungkyunkwan University, Korea)
| 08:00-08:30 | SGLT2 Inhibitors and Cardiovascular Diseases: Lessons, Learnings and the Future Hye jin Yoo (Korea University Guro Hospital, Korea) | Abstract |
- BREAKFAST SYMPOSIUM 5
-
Sep. 7 (Sat.)
08:00~09:00 - Room 2
more
Chairperson
Hyun Ho Shin (Dankook University, Korea)
| 08:00-08:30 | PCSK9 Inhibition after Acute Coronary Syndrome: Who Should Be Treated? Gregory G. Schwartz (University of Colorado, USA) | Abstract |
- BREAKFAST SYMPOSIUM 6
-
Sep. 7 (Sat.)
08:00~09:00 - Room 3
more
Chairperson
Shung Chull Chae (Kyungpook National University, Korea)
| 08:00-08:20 | Practical Use of PCSK9 Inhibitor in Endocrinology Jun Hwa Hong (Eulji University, Korea) | Abstract |
| 08:20-08:40 | The Role of Evolocumab in the Management of ASCVD Patients Kyung Woo Park (Seoul National University, Korea) | |
| 08:40-08:50 | QnA |
- BREAKFAST SYMPOSIUM 1 [AstraZeneca]
-
Sep.10(Fri.)
Chairperson
Jung-hyun Noh (Inje University, Korea)
| 08:00-08:20 | For today for tomorrow, cardiorenal benefit of dapagliflozin Jae Hyuk Lee (Myongji Hospital, Korea) | |
| 08:20-08:30 | Discussion |
- BREAKFAST SYMPOSIUM 2 [Pfizer/BMS]
-
Sep.10(Fri.)
Chairperson
Eung Gyu Kim (Inje University, Korea)
| 08:00-08:20 | Can my elderly AF patients benefit in anticoagulation? : broad data of Eliquis can tell Seung Yong Shin (Chung-Ang University, Korea) | |
| 08:20-08:30 | Discussion |
- BREAKFAST SYMPOSIUM 3 [Sanofi]
-
Sep.10(Fri.)
Chairperson
Seonghoon Choi (Hallym University, Korea)
| 08:00-08:20 | A novel strategy for the lipid management of recent ACS patients - Praluent Jin Joo Park (Seoul National University, Korea) | |
| 08:20-08:30 | Discussion |
- BREAKFAST SYMPOSIUM 4 [Yooyoung]
-
Sep.11(Sat.)
Chairperson
In-Kyung Jeong (Kyung Hee University, Korea)
| 08:00-08:20 | Interim analysis of APOLLO Study: 2 years follow-up results Seung-Woon Rha (Korea University, Korea) | |
| 08:20-08:30 | Discussion |
- BREAKFAST SYMPOSIUM 5 [Chong Kun Dang]
-
Sep.11(Sat.)
Chairperson
Moon-Kyu Lee (Eulji University, Korea)
| 08:00-08:20 | How to manage vascular health with statin in Korean patient: evidence based medicine LIPILOU Jong-Young Lee (Sungkyunkwan University, Korea) | |
| 08:20-08:30 | Discussion |
- BREAKFAST SYMPOSIUM 6 [Celltrion/Jeil Pharmaceutical]
-
Sep.11(Sat.)
Chairperson
Eun-Jung Rhee (Sunkyunkwan University, Korea)
| 08:00-08:20 | CV safety of Alogliptin in T2DM patients Jae Hyoung Park (Korea University, Korea) | |
| 08:20-08:30 | Discussion |
- Organized by
-
The Korean Society of Lipid and Atherosclerosis
- Tel : +82-2-3272-5330
- Fax : +82-2-3272-5331
- Email : ksla@lipid.or.kr
- Business Registration Number : 110-82-60956
- Chairman : Joong-Yeol Park
-
Secretariat of ICoLA 2019 │ People & Value, Inc.
- Tel: +82-2-2135-3617, 3618, 3621
- Fax: +82-2-564-2123
- E-mail: secretariat@icola.org
Copyrights 2019 © The Korean Society of Lipid and Atherosclerosis. All rights reserved.